Wash. Rev. Code § 69.51.010
Short title
This chapter may be cited as the Controlled Substances Therapeutic Research Act.
Revised Code of Washington Chapter 69.51 — Controlled Substances Therapeutic Research Act
Washington · statute · Wash. Rev. Code ch. 69.51 · 7 active provisions
Wash. Rev. Code § 69.51.020
Legislative purpose
The legislature finds that recent research has shown that the use of cannabis may alleviate the nausea and ill effects of cancer chemotherapy and radiology, and, additionally, may alleviate the ill effects of glaucoma. The legislature further finds that there is a need for further research and experimentation regarding…
Wash. Rev. Code § 69.51.030
Definitions
As used in this chapter:(1) "Cannabis" means all parts of the plant of the genus Cannabis L., whether growing or not, the seeds thereof, the resin extracted from any part of the plant, and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin;(2) "Commission" means the…
Wash. Rev. Code § 69.51.040
Controlled substances therapeutic research program
(1) There is established in the commission the controlled substances therapeutic research program. The program shall be administered by the department. The commission shall promulgate rules necessary for the proper administration of the Controlled Substances Therapeutic Research Act. In such promulgation, the commissio…
Wash. Rev. Code § 69.51.050
Patient qualification review committee
(1) The commission shall appoint a patient qualification review committee to serve at its pleasure. The patient qualification review committee shall be comprised of:(a) A physician licensed to practice medicine in Washington state and specializing in the practice of ophthalmology;(b) A physician licensed to practice me…
Wash. Rev. Code § 69.51.060
Sources and distribution of cannabis
(1) The commission shall obtain cannabis through whatever means it deems most appropriate and consistent with regulations promulgated by the United States food and drug administration, the drug enforcement agency, and the national institute on drug abuse, and pursuant to the provisions of this chapter.(2) The commissio…
Wash. Rev. Code § 69.51.080
Cannabis and related products considered Schedule II substances
(1) The enumeration of tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols in RCW 69.50.204 as a Schedule I controlled substance does not apply to the use of cannabis, tetrahydrocannabinols, or a chemical derivative of tetrahydrocannabinols by certified patients pursuant to the provisions of this c…